-
Enriching Education
Students Join Safe-Cracking Competition
Reporter Newspapers
The Safe-Cracking Club at the Weber School in Sandy Springs (near Atlanta) was one of dozens of teams from all over the world to travel to the Weizmann campus and challenge other teams to break into their safes. But they were the only team to place first among Americans. The annual safecracking tournament challenges high schoolers to use physics to construct a secure safe.
April 03, 2017
-
Improving Health & Medicine
Could Erasing Traumatic Memories One Day Eradicate PTSD?
Israel21c
Israel21c reports on research by optogenetics pioneer Dr. Ofer Yizhar. Working with Weizmann colleague Prof. Rony Paz and others, Dr. Yizhar showed that weakening the communication between two parts of the brain reduced fear levels in mice. “This new technique may one day help extinguish traumatic memories in humans – for example, in people with post-traumatic stress disorder, or PTSD.”
April 02, 2017
-
Improving Health & Medicine
New Clues Help Doctors Cure Patients, Not Diseases
Israel21c
Israel21c covers the Nancy and Stephen Grand Israel National Center of Personalized Medicine at the Weizmann Institute, including discussion with Dr. Berta Strulovici, the center’s founding director. The G-INCPM is already studying acute myeloid leukemia, soft-tissue sarcoma, and retinitis pigmentosa.
March 27, 2017
-
Improving Health & Medicine
Taking an Innovative Nontoxic Approach to Lice
Israel21c
Lice are a perennial plague upon schoolchildren – and their parents. This is particularly true because the miniscule parasites are very difficult to get rid of. Israel21c reports on two new Israeli methods, including Novokid: developed by Weizmann grads, it's a nontoxic, highly effective treatment system that is on track for approval in Europe and the U.S.
March 12, 2017
-
Improving Health & Medicine
NeuroSense to Develop ALS Treatment
Globes
Prof. Eran Hornstein discovered that a small molecule already on the market for a different disease can also be active in treating ALS. As
Globes reports, NeuroSense Therapeutics will develop the technology; since ALS is considered a priority, NeuroSense believes that it will be able to bring the drug to market within five years.March 08, 2017
-
Fighting Cancer
Miracle Drug with Israeli Roots Saves Jewish Hockey Player Hit With Cancer
JTA
The Israel Cancer Research Fund (ICRF), which supports cancer research at Weizmann, shares the story of Jewish hockey player Sam Fields, who was felled by aggressive CML just before turning pro. His life was saved, thanks to Gleevec, for which the Institute’s Prof. Eli Canaani helped lay the foundation.
March 08, 2017
-
Enriching Education
AJA Safecrackers Going to Israel
Atlanta Jewish Times
As the Atlanta Jewish Times reports, students from the Atlanta Jewish Academy are taking part in the Weizmann Institute’s International Safe-Cracking Tournament for the second consecutive year. In the tournament, teams from all over the world use the principles of physics to build a safe, and try to break into each other's constructions.
March 06, 2017
-
Exploring the Physical World
A Black Hole? Where?
The Jerusalem Post
Guy Nir, a doctoral student at the Weizmann Institute, writes in The Jerusalem Post about black holes - e.g., what they are, how they are studied, and the like. This easy-to-read explanation sheds light on some of today’s greatest astrophysics discoveries.
March 02, 2017
-
Fighting Cancer
Weizmann Professor to Receive Israel Prize for Groundbreaking Cancer Research
The Jerusalem Post
Prof. Yosef Yarden, “among the most important cancer researchers in the world,” is receiving the 2017 Israel Prize in Life Science Research. Prof. Yarden discovered the function of an enzyme that leads to cancer, a finding that laid the foundation for the development of new cancer treatments. The Israel Prize is considered the country’s highest honor.
March 02, 2017